Squalene is a natural oily liquid hydrocarbon found in plants and animals. Squalene is commonly found in large quantities in shark liver oil. It is the most common lipid produced by human skin cells, making up approximately 10 percent of our sebum. The rise in demand from different applications such as cosmetics and pharmaceuticals and its benefits on human health fuel the squalene market.
The global squalene market is anticipated to reach $214 million by 2022 compared to $110 million in 2015 growing at a CAGR of 10.1% during the forecast period. It is segmented based on source, end-use industry, and geography. The rise in awareness of its health benefits has resulted in the increased demand for squalene. Also, the steady rise in the cosmetics industry and increase in disposable income in developing countries such as China and India are responsible for the increase in demand for squalene in the region. In addition, it is used in health foods, vaccines, and as a high-grade machine lubricant.
Based on the source, squalene market is segmented as shark liver, vegetables, and synthetic biotechnology. Vegetable-sourced squalene is expected to be the fastest-growing segment due to its renewable nature, steady availability of raw material, and regulations regarding animal-sourced squalene.
Based on the end-use industry, squalene market is segmented as cosmetics, food supplements, and healthcare. Cosmetics industry dominated the squalene market in 2015, owing to the rise in awareness for using high quality products and willingness to pay premium prices for high quality products.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Europe led the market in 2015, and is anticipated to maintain this trend during the forecast period owing to vast potential that can be realized soon because of the growth of various end-use industries. The use of animal-sourced squalene dominates the Asia-Pacific market owing to high investments in the cosmetics end-use industry in China, Japan, and South Korea.
The companies profiled in the report include:
Arista Industries Inc.
Empressa Figueirrense de Pesca, LDA.
Kshimoto Special Liver Oil Co. Ltd.
New Zealand Green Health Ltd.
Maruha Nichiro Corporation
Seadragon Marine Oils Limited
Croda International PLC
KEY MARKET BENEFITS
This report provides an extensive analysis of the current trends, future estimations, and dynamics from 2014 to 2022 of the global squalene market, which assists to identify the prevailing opportunities.
Geographically, the market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
Exhaustive analysis predicts the applications that are currently used along with the variants that would gain prominence in the future.
Competitive intelligence of leading manufacturers and distributors highlights the competitive scenario across the geographies
Key market players are profiled and their strategies are analyzed thoroughly, which portrays the competitive outlook
KEY MARKET SEGMENTS:
Global Squalene Market is segmented as:
BY END-USE INDUSTRY
Rest of Europe
Rest of Asia-Pacific
Rest Of LAMEA
1.1. Report description
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. Key findings
2.2. CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. key findings
3.2.1. Top investment pockets
3.3. Top Winning Strategies
3.4. Porters Five Forces Analysis
3.4.1. BARGAINING POWER OF SUPPLIERS
3.4.2. BARGAINING POWER OF BUYERS
3.4.3. THREAT OF SUBSTITUTES
3.4.4. THREAT OF NEW ENTRANTS
3.4.5. INTENSITY OF COMPETITIVE RIVALRY
3.4.6. Market dynamics
184.108.40.206. Growth of cosmetics industry
220.127.116.11. Increase in value and potential of dietary supplements
18.104.22.168. Squalene as a chemo-preventive agent
22.214.171.124. Government rules and regulations
126.96.36.199. Squalene as an antioxidant and immune system support
3.5. Product bench marking
3.6. patent analysis
CHAPTER 4 SQUALENE MARKET, BY SOURCE
4.2. Shark Liver
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. synthetic biotechnology
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 SQUALENE MARKET, BY END USE INDUSTRY
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
188.8.131.52. Skin care
184.108.40.206. Hair care
5.2.3. Market size and forecast
5.3. food supplements
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
220.127.116.11. Cancer treatment
18.104.22.168. Heart disease
22.214.171.124. Skin health
5.4.3. Market size and forecast
CHAPTER 6 SQUALENE MARKET, BY GEOGRAPHY
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.9. Rest of Europe
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.8. Rest of Asia-Pacific
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.7. Saudi Arabia
6.5.8. Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1. amyris, inc.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves and developments
7.2. Croda international plc
7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments
7.3. seadragon marine oils limited
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments
7.4. Maruha nichiro corporation
7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.5. New Zealand Green Health Ltd.
7.5.1. Company overview
7.5.2. Operating business segments
7.6. Gracefruit limited
7.6.1. Company overview
7.6.2. Operating business segments
7.7. Kshimoto special liver oil co., ltd.
7.7.1. Company overview
7.7.2. Operating business segments
7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Key strategic moves and developments
7.9. Empresa figueirense de pesca, lda
7.9.1. Company overview
7.9.2. Operating business segments
7.10. Arista industries inc.
7.10.1. Company overview
7.10.2. Operating business segments
Growth of the end-use industries such as cosmetics, nutraceuticals, and healthcare industry is expected to fuel the market growth during the forecast period. Growth in use of squalene as a chemo-preventive agent, and the increase in value and potential of dietary supplements derived from squalene drives the global squalene market. Government regulations to stop shark killing for squalene extraction is expected to affect the growth of the global squalene market during the forecast period.
Food supplement is the fastest growing market due to rise in demand of the squalene products. The leading market players such as Amyris, Inc., and Croda International plc exhibit a strong brand image because of their diverse product offerings and hence, there is a low threat of new entrants in this market. In addition, requirement of high capital investment and difficulties in availability of raw material due to ban on shark fishing by government indicate a low threat of new entrants. These dominant players have captured major market share, thereby benefiting from the economy of scale. Furthermore, there is high cost of squalene produced from vegetable and there is high cost in research and development of synthetic biotechnology.
The demand for squalene from vegetable sources are projected to witness significant growth owing to the stringent government regulation regarding the ban on killing of shark. More and more companies are shifting towards organic sources to reduce the shark liver oil usage. Olives account for the highest share in the market while amaranth seeds are also good alternatives to olives.
Key Findings of the Squalene Market:
Squalene in cosmetics application segment occupied the highest share in 2015, and is expected to grow at a CAGR of 9.8% in terms of value during the forecast period.
Japan is the leading consumer of squalene accounting for more than one-third share of the Asia-Pacific market, followed by China.
The synthetic bio-technology sourced squalene segment is expected to expand with the highest CAGR of 11.7% in terms of value during the forecast period.
Vegetable sourced squalene segment accounted for approximately half of the global squalene market in 2015.
U.S. is the leading market for squalene in the North American region, growing at a CAGR 6.4% in terms of value during the forecast period.
Europe accounted for the largest share in the global squalene market in 2015, while Asia-Pacific is projected to be the highest growing market for squalene during the forecast period. This is attributable to increase in cosmetics segment and rise in health concerns in the region. India is the fastest growing country of the region for the consumption of squalene, which is expected to continue this dominance.
In response to the rise in need of squalene based products Amyris, Inc. (February 2014), made an agreement with Dowell C&I Co., Ltd., to distribute and expand personal care business in Asia. Dowell has become a distributor of Neossance in Korea. This agreement led to the expansion of business in the Asia-Pacific region. The prominent players profiled in this report include Seadragon Marine Oils Limited, Arista Industries Inc., Maruha Nichiro Corporation, Gracefruit Limited, Kishimoto Special Liver Oil Co. Ltd., Amyris Inc., New Zealand Green Health Ltd., Carbomer, Asha Biochem, and Croda International PLC.
- Arista Industries Inc.
- Empressa Figueirrense de Pesca, LDA.
- Kshimoto Special Liver Oil Co. Ltd.
- Gracefruit Limited
- New Zealand Green Health Ltd.
- Maruha Nichiro Corporation
- Seadragon Marine Oils Limited
- Croda International PLC
- Amyris Inc.